上置集團(01207.HK)主席兼行政總裁接受內地公安部門調查
上置集團(01207.HK)公布,公司獲執行董事兼董事會主席及行政總裁彭心曠的家人通知,中國公安部門要求彭心曠因個人原因接受調查並採取了限制措施,無法與其正常聯繫,故彭心曠暫時無法履行其職務。
公司指,並無就該等措施收到公安部門或任何其他監管、政府或司法機構的任何通知或法律文件。除上述由彭心曠家人提供的信息外,並不知悉任何其他與該等措施有關的資料。
公司認為,該等措施現時對集團的經營或財務狀況是否產生重大不利影響需評估確定,已於昨日(19日)委任執行董事朱強為公司代理行政總裁,朱強將處理公司行政總裁的職務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.